",{"id":"SIGNIN"}).html('
×
').appendTo("body");jQuery("#SIGNIN").on('click',function(e){closeLogin()})},closeLogin=function(){jQuery("#SIGNIN").remove();jQuery("body").css("overflow","inherit")},adjustLoginHeight=function(h){jQuery("#Oframe").height(h)},login_success=function(sess){jQuery(".sign-up").html("LOGOUT").on('click',function(){location.href="https://signin."+DOMAIN+"/oauth/logout"});closeLogin()},LANG='en',commentHeight=function(data){jQuery("#block-ibt-comment iframe").height(data.height)};var login_success=function(sess){closeLogin();jQuery("article").removeClass("wall");jQuery(".login-btn .sign-up2").hide();jQuery(".login-btn .myaccount").show();jQuery(".only-before-login").hide();if(typeof sess=='object'){sess=sess.sess};jQuery("
",{"id":"TEMPE"}).html('').appendTo("body");jQuery("#TEMPE iframe").on("load",function(){jQuery("#TEMPE").remove();if(jQuery("iframe.comment").length){jQuery("iframe.comment").get(0).contentWindow.postMessage({'action':'success',},'*')}});afterLogin()};function afterLogin(){};doFir.push(function(){jQuery(document).ready(function(){jQuery(".sign-up2").on('click',function(e){e.preventDefault();e.stopPropagation();openLogin('https://signin.'+DOMAIN.replace(/ibtimes\.[\.a-z]+/,'ibtimes.com')+'/oauth?l='+jQuery(this).attr('data-lang'))})})})
A new drug developed by BioMarin Pharmaceuticals showed promise in lowering phenylalanine in the blood of patients with phenylalanine hydroxylase deficiency. However, it failed to show benefit in mood complications and inattention.